HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guy Jerusalem Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

6/2021From modified radical mastectomy to infra-radical mastectomy: a phase I study for surgical de-escalation focusing on pathological analyses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guy Jerusalem Research Topics

Disease

88Breast Neoplasms (Breast Cancer)
12/2023 - 09/2002
60Neoplasms (Cancer)
10/2023 - 09/2002
8Triple Negative Breast Neoplasms
01/2023 - 12/2014
8Neoplasm Metastasis (Metastasis)
01/2021 - 03/2011
7Fatigue
11/2022 - 05/2014
5Disease Progression
12/2023 - 11/2013
5Lymphoma (Lymphomas)
09/2005 - 09/2002
4Neutropenia
01/2021 - 05/2014
3Cardiotoxicity
09/2021 - 01/2019
3Melanoma (Melanoma, Malignant)
08/2021 - 08/2013
3Diarrhea
01/2021 - 01/2019
3Inflammation (Inflammations)
01/2021 - 04/2003
3Febrile Neutropenia
04/2020 - 05/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2020
2Cognitive Dysfunction
11/2022 - 11/2022
2Pneumonia (Pneumonitis)
11/2022 - 01/2021
2Pain (Aches)
01/2022 - 12/2020
2Stomatitis
01/2021 - 05/2014
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2020
2Carcinoma (Carcinomatosis)
01/2020 - 07/2015
1Biliary Tract Neoplasms (Biliary Tract Cancer)
09/2023
1Death (Near-Death Experience)
06/2023
1Brain Neoplasms (Brain Tumor)
12/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
11/2022
1Frailty
11/2022
1Eosinophilia
05/2022

Drug/Important Bio-Agent (IBA)

32Hormones (Hormone)IBA
10/2023 - 02/2012
14EverolimusFDA Link
12/2022 - 01/2011
14Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2015
13ErbB Receptors (EGF Receptor)IBA
12/2023 - 01/2016
12Fulvestrant (Faslodex)FDA Link
01/2022 - 10/2010
10Trastuzumab (Herceptin)FDA Link
09/2023 - 03/2007
10Estrogen ReceptorsIBA
10/2018 - 10/2010
9Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2003
8Epidermal Growth Factor (EGF)IBA
12/2023 - 11/2013
8Aromatase InhibitorsIBA
10/2018 - 02/2012
7ribociclibIBA
01/2022 - 01/2018
6Letrozole (Femara)FDA LinkGeneric
11/2022 - 02/2012
6exemestane (Aromasin)FDA Link
01/2021 - 01/2014
5abemaciclibIBA
10/2023 - 01/2021
4Cyclin-Dependent Kinase 4IBA
05/2024 - 01/2021
4palbociclibIBA
12/2023 - 01/2019
4Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 10/2015
4Immune Checkpoint InhibitorsIBA
01/2023 - 01/2021
4Matrix Metalloproteinase 17IBA
02/2022 - 12/2014
4AnthracyclinesIBA
09/2021 - 01/2015
4MicroRNAs (MicroRNA)IBA
01/2021 - 02/2015
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2006 - 04/2003
3TamoxifenFDA LinkGeneric
10/2023 - 01/2021
3human ERBB2 proteinIBA
01/2021 - 01/2014
3pertuzumabIBA
01/2021 - 01/2019
3olaparibIBA
11/2018 - 10/2015
3Messenger RNA (mRNA)IBA
01/2018 - 03/2015
3EnzymesIBA
01/2018 - 07/2015
2Anastrozole (Arimidex)FDA LinkGeneric
12/2023 - 11/2022
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2023 - 10/2016
2pembrolizumabIBA
11/2022 - 01/2019
2Metalloproteases (Metalloproteinases)IBA
02/2022 - 12/2014
2Coloring Agents (Dyes)IBA
02/2022 - 09/2021
2Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2020 - 01/2019
2Methotrexate (Mexate)FDA LinkGeneric
08/2020 - 08/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2020 - 03/2019
2Colony-Stimulating Factors (Colony Stimulating Factor)IBA
04/2020 - 03/2019
2avelumabIBA
01/2020 - 01/2018
2LigandsIBA
10/2019 - 01/2018
2Retinoblastoma ProteinIBA
01/2019 - 12/2014
2trebananibIBA
01/2019 - 06/2015
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 03/2017
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 06/2015
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2017 - 03/2007
2Progesterone Receptors (Progesterone Receptor)IBA
01/2016 - 11/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015 - 08/2013
2taxaneIBA
01/2015 - 05/2014
2benthiocarb (Bolero)IBA
05/2014 - 01/2014
2Vinorelbine (Navelbine)FDA LinkGeneric
05/2014 - 01/2011
2MTOR InhibitorsIBA
01/2014 - 11/2013
2TOR Serine-Threonine KinasesIBA
01/2014 - 11/2013
1NivolumabIBA
12/2023
1Circulating Tumor DNAIBA
10/2023
1tucatinibIBA
09/2023
1anlotinibIBA
01/2023
1trastuzumab deruxtecanIBA
12/2022
1sacituzumab govitecanIBA
12/2022
1dalpiciclibIBA
11/2022
1pyrotinibIBA
11/2022
1Transaminases (Aminotransferases)IBA
11/2022
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2022

Therapy/Procedure

46Therapeutics
10/2023 - 09/2002
29Drug Therapy (Chemotherapy)
10/2023 - 09/2002
9Hypnosis (Mesmerism)
10/2023 - 04/2017
5Neoadjuvant Therapy
12/2023 - 02/2015
4Aftercare (After-Treatment)
11/2020 - 09/2002
4Radiotherapy
01/2019 - 01/2016
3Activities of Daily Living (ADL)
11/2022 - 01/2021
2Radical Mastectomy
09/2021 - 06/2021
2Immunotherapy
08/2021 - 01/2021
2Chemoradiotherapy
01/2021 - 11/2020
1Terminal Care (Care, Terminal)
06/2023
1Palliative Care (Palliative Therapy)
06/2023
1Polypharmacy
11/2022